Vaginal Atrophy News and Research

RSS
Post-menopausal Conversations: Why You Should Talk to Your Clinician

Post-menopausal Conversations: Why You Should Talk to Your Clinician

Maturitas provides new holistic model of care for healthy menopause

Maturitas provides new holistic model of care for healthy menopause

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

Multicenter trial compares popular treatments for menopause-related vaginal symptoms

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Cynosure obtains medical device license from Health Canada to market MonaLisa Touch for treatment of GSM symptoms

Postmenopausal women who are not aware of VVA consequences continue to experience pain during sex

Postmenopausal women who are not aware of VVA consequences continue to experience pain during sex

VagiCap improves quality of life, satisfaction for postmenopausal women with vulvar and vaginal atrophy

VagiCap improves quality of life, satisfaction for postmenopausal women with vulvar and vaginal atrophy

Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

Aeterna Zentaris signs strategic co-promotion services agreement with ASCEND

New drug delivered through skin effective in treatment of breast cancer

New drug delivered through skin effective in treatment of breast cancer

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

TherapeuticsMD's fourth quarter 2013 net revenue increases to $2.9 million

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

FDA approves InControl Medical's InToneMV device for treatment of female urinary incontinence

British post-menopausal women less likely to access appropriate treatment for vaginal atrophy

British post-menopausal women less likely to access appropriate treatment for vaginal atrophy

Treatment can restore satisfying sex life post menopause

Treatment can restore satisfying sex life post menopause

Research findings provide new hope for people suffering from dry eye disease

Research findings provide new hope for people suffering from dry eye disease

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

EMA accepts Shionogi's ospemifene MAA for treatment of VVA in post-menopausal women

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Pfizer, Ligand announce FDA acceptance of bazedoxifene/conjugated estrogens NDA

Pfizer, Ligand announce FDA acceptance of bazedoxifene/conjugated estrogens NDA

EMAS clinical guide on low-dose vaginal estrogens for postmenopausal vaginal atrophy

EMAS clinical guide on low-dose vaginal estrogens for postmenopausal vaginal atrophy

EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

EMA accepts Pfizer’s bazedoxifene/conjugated estrogens MAA for review

Bayer receives FDA approval for lower dose formulation of ANGELIQ

Bayer receives FDA approval for lower dose formulation of ANGELIQ